Original Source(s)
Related Content
AI may predict focal GBM recurrence
Optical analysis of resection-margin tissue identified tumor infiltration as the strongest contributor to predictions of where glioblastoma later recurred.
October 15, 2026
-
4 min
FDA expands talazoparib use in prostate cancer
The combination with enzalutamide reduced the risk of radiographic progression or death by 52% .
by Mouj Hijazi
October 27, 2026
-
3 min
FDA expands essential thrombocythemia care
Phase 3 SURPASS ET data showed higher durable response rates with ropeginterferon alfa-2b-njft than with anagrelide.
September 1, 2026
-
2 min